Tuesday 24/March/2026 – 06:43 PM
A study conducted by researchers at Stanford University revealed the development of immunotherapy capabilities by providing the body’s cells with customized, targeted protein receptors that turn them into precise tracking tools capable of detecting and destroying malignant cells with complete efficiency.
Modern medical technology turns immune cells into lethal tools for penetrating tumors
According to Medical
Extensive laboratory experiments have proven that this approach significantly doubles survival rates and gives new hope to patients with breast and ovarian cancers, establishing a decisive and pivotal stage in the path of immunotherapy directed at eliminating intractable tumors radically and permanently.
Challenges of spatial penetration
CAR-T cell technologies have truly revolutionized the treatment of blood cancers since their official approval in 2017, but they have faced severe difficulties when trying to apply them to solid tumors.
According to the same source, Dr. Livnat Jerby, an assistant professor of genetics at Stanford University, explained that the main problem lies in spatial obstacles, as the cells are depleted of energy and become exhausted before they can penetrate the dense tumor masses. To confront this medical challenge, the scientific team sought to discover alternative methods that would increase the efficiency of immunotherapy and direct it with extreme precision, through a comprehensive search for genes that stimulate the migration of killer cells and direct them directly towards the tumor environment.
Metabolic tracking and cell compass
According to the same study, researchers used CRISPR gene-editing technology to activate specific genes within natural killer NK cells, by analyzing large-scale genetic data from hundreds of patients.
The laboratory team surprisingly discovered that G-protein-coupled receptors (GPCRs) act as a very precise sensor compass, detecting pathways for metabolic products, such as oxidized cholesterol, secreted by cancer cells during their rapid, random growth. This intelligent chemical tracking is like hounds following footprints, driving the immunotherapy directly into the heart of the solid tumor to surround and destroy it from within with great efficiency.
Promising results and clinical trials
According to Medical
Dr. Gerbe confirmed that the laboratory mice that underwent the experiment completely recovered without any signs of a return of the disease, which opens the door wide for the start of clinical trials soon to apply the technology to humans, as this smart and unique exploitation of cancer metabolism represents an unprecedented medical strategy aimed at transforming the strengths of tumors into a fatal weakness that facilitates their final elimination.
